Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.00
Bid: 77.00
Ask: 77.10
Change: -0.20 (-0.26%)
Spread: 0.10 (0.13%)
Open: 76.60
High: 77.15
Low: 76.60
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV and proposed Placing under Placing Programme

8 Sep 2014 07:00

RNS Number : 0140R
GCP Infrastructure Investments Ltd
08 September 2014
 



GCP Infrastructure Investments Limited

(the "Company")

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

 

This announcement is an advertisement and not a prospectus. Any decision to invest in the securities referred to in this announcement must be made exclusively on the basis of the prospectus published on 12 February 2014 by the Company and any supplement thereto (the "Prospectus"). A copy of the Prospectus is available for inspection at www.morningstar.co.uk/uk/NSM. This announcement does not constitute a recommendation regarding any securities.

 

 NAV and proposed Placing under Placing Programme

8 September 2014

Net Asset Value of the Company's Shares

 

As at close of business on 29 August 2014 (being the last business day of the month), the unaudited net asset value per Ordinary Share of the Company was 103.71 pence. The net asset value takes into account cash, other assets, accrued liabilities and expenses and leverage (if any) of the Company attributable to the Ordinary Share class.

 

Placing under the Placing Programme

 

The Board of Directors of the Company is pleased to announce a proposed initial placing of new ordinary shares of £0.01 each of the Company ("Ordinary Shares") seeking to raise up to £20 million of gross proceeds under the Placing Programme in accordance with the Prospectus published on 12 February 2014 (the "Placing").

 

The Placing is being proposed in order to allow the Company to take advantage of a number of attractive immediate investment opportunities in accordance with the Company's investment objective and policy. The existing cash resources of the Company, together with the net proceeds of the Placing, are intended to be deployed by the Company in these opportunities in accordance with its investment policy.

 

The Placing will be non pre-emptive and shall commence immediately following this announcement.

 

Qualified investors should communicate their firm interest to their usual sales contact at either Oriel Securities Limited ("Oriel) or Cenkos Securities plc ("Cenkos"), providing a clear indication of the number of new Ordinary Shares which such qualified investor wishes to subscribe for under the Placing, and the price that the prospective investor is willing to pay.

 

The number and price (the "Placing Price") of the new Ordinary Shares to be issued will be determined as at the close of the bookbuild for the Placing at 3pm on 15 September 2014 and announced on 16 September 2014. The Placing Price per Ordinary Share will be at a premium to the prevailing NAV.

 

The decision to allot any new Ordinary Shares to any qualified investors shall be at the discretion of the Company, Oriel and Cenkos. Oriel and Cenkos reserve the right, after consultation with the Company, to scale back applications under the Placing at their absolute discretion in such amounts as they consider appropriate.

 

Application will be made to the UK Listing Authority for all of the new Ordinary Shares issued pursuant to the Placing to be admitted to the premium segment of the Official List and for all such new Ordinary Shares to be admitted to trading on the London Stock Exchange's main market for listed securities. It is expected that such admission will become effective and dealings in such new Ordinary Shares will commence not later than 19 September 2014.

 

The timetable is subject to change at the discretion of the Company, Oriel and Cenkos.

 

 

Contact details:

 

Gravis Capital Partners LLP

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

Oriel Securities

+44 (0)20 7710 7600

Neil Winward

Mark Bloomfield

Tunga Chigovanyika

Cenkos Securities

Tom Scrivens

+44 (0)20 7397 1915

Buchanan

+44 (0)20 7466 5000

Charles Ryland

Sophie McNulty

 

About GCP Infrastructure Investments Limited

The Company is a closed-ended London Stock Exchange-listed investment company that seeks to generate returns from senior and subordinated infrastructure debt and related and/or similar assets. The Company is advised by Gravis Capital Partners LLP.

 

Members of the public are not eligible to take part in the Placing. This announcement and the terms and conditions referred to herein are directed in the United Kingdom only at persons selected by Oriel Securities Limited or Cenkos Securities plc who are "investment professionals" falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "FPO") or "high net worth companies, unincorporated associations etc" falling within Article 49(2) of the FPO, or persons to whom it may otherwise be lawfully communicated (all such persons together being referred to as "Relevant Persons"). This announcement and the terms and conditions referred to herein must not be acted on or relied on in the United Kingdom by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to, and will be engaged in only with, persons in the United Kingdom who are Relevant Persons.

 

The new Ordinary Shares that are the subject of the Placing are not being offered or sold to any person in the European Union, other than to "qualified investors" as defined in Article 2.1(e) of Directive 2003/71/EC, which includes legal entities which are regulated by the Financial Conduct Authority or entities which are not so regulated whose corporate purpose is solely to invest in securities.

 

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or South Africa or into any other jurisdiction where applicable laws prohibit its release, distribution or publication. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or South Africa or in any other jurisdiction where such offer or sale would be unlawful. The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or the US Investment Company Act of 1940, as amended and may not be offered or sold directly or indirectly in or into the United States or to or for the account or benefit of any US Person (within the meaning of Regulation S under the Securities Act). The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa.

 

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by, Oriel Securities Limited, Cenkos Securities plc or by any of their respective affiliates or agents as to or in relation to the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or their advisers and any liability therefore is expressly disclaimed.

 

Oriel Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as joint broker and joint bookrunner to the Company and is acting for no-one else in connection with the Placing and the contents of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Oriel Securities Limited nor for providing advice in connection with the Placing and the contents of this announcement or any other matter referred to herein.

Cenkos Securities plc, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as joint broker and joint book runner to the Company and is acting for no-one else in connection with the Placing and the contents of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Cenkos Securities plc nor for providing advice in connection with the Placing and the contents of this announcement or any other matter referred to herein.

End of Announcement

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDELFBZKFBBBZ
Date   Source Headline
15th Jul 20164:02 pmRNSInvestor Report - 30 June 2016
15th Jul 201611:32 amRNSNotification of Major Interest in Shares
14th Jul 20162:29 pmRNSDividend Declaration
13th Jul 201612:45 pmRNSNotification of Major Interest of Shares
13th Jul 201612:43 pmRNSNotification of Major Interest in Shares
12th Jul 201610:43 amRNSNotification of Major Interest in Shares
8th Jul 20162:46 pmRNSPlacing under the Placing Programme
6th Jul 201612:21 pmRNSPlacing under the Placing Programme
4th Jul 20161:51 pmRNSNAV and proposed placing under placing programme
31st May 201612:32 pmRNSTotal Voting Rights
27th May 20167:00 amRNSHalf Year Financial Report & Financial Statements
19th May 20163:48 pmRNSAdditional Listing
29th Apr 201610:33 amRNSSCRIP Dividend Circular
20th Apr 20162:51 pmRNSTR-1: Notification of Major Interest in Shares
19th Apr 20161:52 pmRNSTR-1: Notification of Major Interest in Shares
18th Apr 20164:24 pmRNSPublication of a Prospectus
15th Apr 20164:09 pmRNSRefinancing of investment & pay-down debt facility
14th Apr 20165:30 pmRNSDividend Declaration
14th Apr 20165:29 pmRNSResults of Extraordinary General Meeting
13th Apr 20165:02 pmRNSDirector/PDMR Shareholding
13th Apr 20163:37 pmRNSTR-1: Notification of Major Interest in Shares
13th Apr 20163:36 pmRNSInvestor Report 31 March 2016
6th Apr 20165:38 pmRNSNet Asset Value(s)
4th Apr 20163:02 pmRNSNotification of Major Interest in Shares
1st Apr 20164:58 pmRNSDirector/PDMR Shareholding
1st Apr 20167:00 amRNSCompliance with Model Code
23rd Mar 20164:50 pmRNSNotice of EGM
23rd Mar 20161:50 pmRNSDirector/PDMR Shareholding
16th Mar 201610:37 amRNSInvestor Report 29 February 2016
3rd Mar 20164:29 pmRNSConfirmation of corporate broking arrangements
3rd Mar 201611:41 amRNSNet Asset Value(s)
29th Feb 201612:52 pmRNSTotal Voting Rights
25th Feb 201612:47 pmRNSInvestor Report 31 January 2016
24th Feb 20163:04 pmRNSNotification of Major Interest in Shares
18th Feb 20164:02 pmRNSNotification of Major Interest in Shares
18th Feb 20164:01 pmRNSNotification of Major Interest in Shares
18th Feb 20164:01 pmRNSHome Member State
16th Feb 20163:57 pmRNSAdditional Listing
12th Feb 20164:10 pmRNSResult of AGM
4th Feb 20166:13 pmRNSNet Asset Value(s)
29th Jan 20165:05 pmRNSScrip Dividend Circular
14th Jan 20164:54 pmRNSDividend Declaration
12th Jan 20164:29 pmRNSNotice of AGM
6th Jan 20163:38 pmRNSNet Asset Value(s)
31st Dec 201512:24 pmRNSTotal Voting Rights
18th Dec 20152:07 pmRNSPublication of Supplementary Prospectus
18th Dec 20157:00 amRNSAnnual Financial Report
10th Dec 20155:29 pmRNSTotal Voting Rights
7th Dec 20157:00 amRNSResults of Placing and Additional Listing
3rd Dec 20157:00 amRNSNet Asset Valuation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.